100 Million Vaccine Doses By End Of June

1
>>Follow Matzav On Whatsapp!<<

Johnson & Johnson said Tuesday that it is on track to meet its target of 100 million coronavirus vaccine doses for the United States by the end of June, one of a string of confident announcements on vaccine supply.

Johnson & Johnson is being closely watched as a potential third vaccine for the U.S., helping further an increase in available doses. The company said Tuesday that it expects results from its Phase 3 trial “by early next week.”

If the vaccine proves to be safe and effective and is authorized in the coming weeks, the company’s chief financial officer, Joseph Wolk, told CNBC: “We’re very confident and on track to meet all of our commitments, which would include 100 million doses to the U.S. by the end of June.”

Read more at The Hill.

{Matzav.com}

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here